CochLear Operating Income 2023-2024 | CHEOY

CochLear annual/quarterly operating income history and growth rate from 2023 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • CochLear operating income for the quarter ending December 31, 2024 was $0M, a 0% increase year-over-year.
  • CochLear operating income for the twelve months ending December 31, 2024 was $0M, a 0% increase year-over-year.
  • CochLear annual operating income for 2024 was $0.312B, a 18.8% increase from 2023.
  • CochLear annual operating income for 2023 was $0.262B, a 9.64% decline from 2022.
  • CochLear annual operating income for 2022 was $0.29B, a 74.83% decline from 2021.
CochLear Annual Operating Income
(Millions of US $)
2024 $312
2023 $262
2022 $290
2021 $1,153
2020 $887
2019 $1,020
2018 $1,057
2017 $945
2016 $824
CochLear Quarterly Operating Income
(Millions of US $)
2024-12-31
2024-06-30
2023-12-31
2023-06-30
2022-06-30
Sector Industry Market Cap Revenue
Medical Medical Services $13.107B $1.488B
Cochlear Limited provides implantable hearing solutions principally in the Americas, Europe, the Middle East, Africa and the Asia Pacific. The company offers cochlear implants, including Nucleus 7 and Kanso sound processors; Carina middle-ear implants and accessories and Baha bone conduction implants. Cochlear Limited is based in Sydney, Australia.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $139.405B 26.15
CVS Health (CVS) United States $80.076B 9.95
Elevance Health (ELV) United States $68.334B 9.16
Cencora (COR) United States $57.058B 19.85
DiDi Global (DIDIY) China $27.204B 28.90
Labcorp Holdings (LH) United States $20.694B 16.78
Natera (NTRA) United States $19.578B 0.00
BioMerieux (BMXMF) France $16.861B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $13.895B 0.00
Solventum (SOLV) United States $12.779B 13.53
ICON (ICLR) Ireland $11.862B 11.03
Revvity (RVTY) United States $11.266B 19.39
Viatris (VTRS) United States $10.880B 3.74
Medpace Holdings (MEDP) United States $9.173B 24.36
Avantor (AVTR) United States $9.056B 13.16
Sonic Healthcare (SKHHY) Australia $8.822B 0.00
HealthEquity (HQY) United States $8.658B 37.92
Caris Life Sciences,�Inc (CAI) United States $7.959B 0.00
Charles River Laboratories (CRL) United States $7.696B 15.08
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $5.017B 29.54
BrightSpring Health Services (BTSG) United States $3.534B 32.42
Sotera Health (SHC) United States $3.188B 18.11
Surgery Partners (SGRY) United States $2.899B 37.70
Alignment Healthcare (ALHC) United States $2.602B 0.00
Concentras Parent (CON) United States $2.533B 14.64
Organon (OGN) United States $2.506B 2.66
GeneDx Holdings (WGS) United States $2.295B 88.37
Progyny (PGNY) United States $1.972B 43.42
PACS (PACS) United States $1.876B 0.00
Premier (PINC) United States $1.735B 13.17
GoodRx Holdings (GDRX) United States $1.689B 33.79
Ardent Health (ARDT) United States $1.656B 7.06
Teladoc Health (TDOC) United States $1.410B 0.00
QDM (QDMI) Hong Kong, SAR China $1.277B 438.00
Establishment Labs Holdings (ESTA) $1.228B 0.00
Pediatrix Medical (MD) United States $1.103B 8.39
Ryman Healthcare (RYHTY) New Zealand $0.970B 0.00
Agilon Health (AGL) United States $0.898B 0.00
AMN Healthcare Services Inc (AMN) United States $0.779B 7.29
CareDx (CDNA) United States $0.658B 10.27
Nutex Health (NUTX) United States $0.615B 9.32
Embecta (EMBC) United States $0.576B 3.88
InnovAge Holding (INNV) United States $0.571B 0.00
SBC Medicals (SBC) United States $0.569B 0.00
So-Young (SY) China $0.507B 0.00
LifeMD (LFMD) United States $0.504B 0.00
Sonida Senior Living (SNDA) United States $0.476B 0.00
Auna S.A (AUNA) Luxembourg $0.474B 10.68
Omada Health (OMDA) $0.456B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.363B 0.00
Enhabit (EHAB) United States $0.337B 27.75
Oncology Institute (TOI) United States $0.326B 0.00
Performant Healthcare (PHLT) United States $0.315B 0.00
Beauty Health (SKIN) United States $0.209B 0.00
DocGo (DCGO) United States $0.148B 24.17
Pheton Holdings (PTHL) China $0.143B 0.00
Sera Prognostics (SERA) United States $0.113B 0.00
Ascend Wellness Holdings (AAWH) United States $0.078B 0.00
KindlyMD (NAKA) United States $0.069B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.059B 0.00
Basel Medical Group (BMGL) Singapore $0.052B 0.00
Biodesix (BDSX) United States $0.046B 0.00
ModivCare (MODV) United States $0.044B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.038B 0.00
OSR Holdings (OSRH) United States $0.019B 0.00
Intelligent Bio Solutions (INBS) United States $0.015B 0.00
BioNexus Gene Lab (BGLC) $0.012B 0.00
Co-Diagnostics (CODX) United States $0.009B 0.00
SeaStar Medical Holding (ICU) United States $0.007B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00